These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 7778548

  • 21. Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial.
    Glick H, Cook J, Kinosian B, Pitt B, Bourassa MG, Pouleur H, Gerth W.
    J Card Fail; 1995 Dec; 1(5):371-80. PubMed ID: 12836712
    [Abstract] [Full Text] [Related]

  • 22. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
    SOLVD Investigators, Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN.
    N Engl J Med; 1992 Sep 03; 327(10):685-91. PubMed ID: 1463530
    [Abstract] [Full Text] [Related]

  • 23. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
    Lam PH, Dooley DJ, Fonarow GC, Butler J, Bhatt DL, Filippatos GS, Deedwania P, Forman DE, White M, Fletcher RD, Arundel C, Blackman MR, Adamopoulos C, Kanonidis IE, Aban IB, Patel K, Aronow WS, Allman RM, Anker SD, Pitt B, Ahmed A.
    Eur J Heart Fail; 2018 Feb 03; 20(2):359-369. PubMed ID: 28980368
    [Abstract] [Full Text] [Related]

  • 24. The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction.
    Kostis JB.
    Am J Hypertens; 1995 Sep 03; 8(9):909-14. PubMed ID: 8541006
    [Abstract] [Full Text] [Related]

  • 25. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.
    Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B.
    Lancet; 1992 Nov 14; 340(8829):1173-8. PubMed ID: 1359258
    [Abstract] [Full Text] [Related]

  • 26. Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.
    Capes SE, Gerstein HC, Negassa A, Yusuf S.
    Diabetes Care; 2000 Mar 14; 23(3):377-80. PubMed ID: 10868869
    [Abstract] [Full Text] [Related]

  • 27. Comparison of treatment with lisinopril versus enalapril for congestive heart failure.
    Zannad F, van den Broek SA, Bory M.
    Am J Cardiol; 1992 Oct 08; 70(10):78C-83C. PubMed ID: 1329478
    [Abstract] [Full Text] [Related]

  • 28. The cost and cardioprotective effects of enalapril in hypertensive patients with left ventricular dysfunction.
    Cook JR, Glick HA, Gerth W, Kinosian B, Kostis JB.
    Am J Hypertens; 1998 Dec 08; 11(12):1433-41. PubMed ID: 9880125
    [Abstract] [Full Text] [Related]

  • 29. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
    Cleland JG, Dargie HJ, Ball SG, Gillen G, Hodsman GP, Morton JJ, East BW, Robertson I, Ford I, Robertson JI.
    Br Heart J; 1985 Sep 08; 54(3):305-12. PubMed ID: 2994698
    [Abstract] [Full Text] [Related]

  • 30. Recruitment strategies in the studies of left ventricular dysfunction (SOLVD): strategies for screening and enrollment in two concurrent but separate trials. The SOLVD Investigators.
    Carew BD, Ahn SA, Boichot HD, Dierenfeldt BJ, Dolan NA, Edens TR, Weiner DH, Probstfield JL.
    Control Clin Trials; 1992 Oct 08; 13(5):325-38. PubMed ID: 1330437
    [Abstract] [Full Text] [Related]

  • 31. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
    Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D.
    N Engl J Med; 1995 Jul 13; 333(2):77-82. PubMed ID: 7539890
    [Abstract] [Full Text] [Related]

  • 32. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG, Crozier IG, Turner JG, Richards AM, Frampton CM, Nicholls MG, Ikram H.
    Am J Cardiol; 1994 Jun 15; 73(16):1180-6. PubMed ID: 8203335
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).
    Chockalingam A, Venkatesan S, Subramaniam T, Jagannathan V, Elangovan S, Alagesan R, Gnanavelu G, Dorairajan S, Krishna BP, Chockalingam V, Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis.
    Am Heart J; 2004 Apr 15; 147(4):E19. PubMed ID: 15077102
    [Abstract] [Full Text] [Related]

  • 35. Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial.
    Gupta V, Kumar Singh S, Agrawal V, Bali Singh T.
    Pediatr Blood Cancer; 2018 Nov 15; 65(11):e27308. PubMed ID: 30009543
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Beneficial clinical effect of very early enalapril treatment in patients with acute left ventricular failure complicating myocardial infarction.
    Hüttl S, Nussberger J, Lehmann K, Hasford J, Brunner HR, Delius W.
    Clin Cardiol; 1995 Jun 15; 18(6):317-23. PubMed ID: 7664505
    [Abstract] [Full Text] [Related]

  • 38. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
    Fletcher RD, Cintron GB, Johnson G, Orndorff J, Carson P, Cohn JN.
    Circulation; 1993 Jun 15; 87(6 Suppl):VI49-55. PubMed ID: 8500239
    [Abstract] [Full Text] [Related]

  • 39. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry.
    Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, Pinkett T, Ghali JK, Wilson AC.
    Am J Cardiol; 1996 May 01; 77(11):1017-20. PubMed ID: 8644628
    [Abstract] [Full Text] [Related]

  • 40. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study.
    Solomon SD, Skali H, Bourgoun M, Fang J, Ghali JK, Martelet M, Wojciechowski D, Ansmite B, Skards J, Laks T, Henry D, Packer M, Pfeffer MA, OVERTURE Investigators.
    Am Heart J; 2005 Aug 01; 150(2):257-62. PubMed ID: 16086927
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.